Nonovarian origins of ovarian cancer

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 10, 2012, Pages 3608-3609

  Hillier, Stephen G ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; MICRORNA; ORAL CONTRACEPTIVE AGENT; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B;

BREAST FEEDING; CANCER GRADING; CANCER RISK; CELL DAMAGE; DNA DAMAGE; EPITHELIUM CELL; HUMAN; HYSTERECTOMY; METASTASIS; MUELLERIAN DUCT; NONHUMAN; NOTE; OVARY CANCER; OVULATION; PATHOGENESIS; PREGNANCY; PRIORITY JOURNAL; RNA SYNTHESIS; SIGNAL TRANSDUCTION; UTERINE TUBE; UTERINE TUBE LIGATION;

ANIMALS; FALLOPIAN TUBES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; OVARIAN NEOPLASMS;

EID: 84857925901     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1201029109     Document Type: Note

References (20)

1. Kim J, et al. (2012) High-grade serous ovarian cancer arises from fallopian tube in a mouse model. Proc Natl Acad Sci USA 109:3921-3926.
2. Fleming JS, Beaugié CR, Haviv I, Chenevix-Trench G, Tan OL (2006) Incessant ovulation, inflammation and epithelial ovarian carcinogenesis: Revisiting old hypotheses. Mol Cell Endocrinol 247:4-21. (Pubitemid 43277703)
3. Salehi F, Dunfield L, Phillips KP, Krewski D, Vanderhyden BC (2008) Risk factors for ovarian cancer: An overview with emphasis on hormonal factors. J Toxicol Environ Health B Crit Rev 11:301-321. (Pubitemid 351451267)
4. Cramer DW (2012) The epidemiology of endometrial and ovarian cancer. Hematol Oncol Clin North Am 26: 1-12.
5. Ricciardelli C, Oehler MK (2009) Diverse molecular pathways in ovarian cancer and their clinical significance. Maturitas 62:270-275.
6. Kurman RJ, Shih IeM (2008) Pathogenesis of ovarian cancer: Lessons from morphology and molecular biology and their clinical implications. Int J Gynecol Pathol 27:151-160. (Pubitemid 351450677)
7. Piek JM, et al. (2003) Expression of differentiation and proliferation related proteins in epithelium of prophylactically removed ovaries from women with a hereditary female adnexal cancer predisposition. Histopathology 43:26-32. (Pubitemid 36836584)
8. Primas H, et al. (2012) Impact of lifestyle factors on preneoplastic changes in prophylactic oophorectomies of BRCA mutation carriers. Eur J Cancer Prev 21:199-204.
9. Przybycin CG, Kurman RJ, Ronnett BM, Shih IeM, Vang R (2010) Are all pelvic (nonuterine) serous carcinomas of tubal origin? Am J Surg Pathol 34:1407-1416.
10. Cibula D, Widschwendter M, Májek O, Dusek L (2011) Tubal ligation and the risk of ovarian cancer: Review and meta-analysis. Hum Reprod Update 17:55-67.
11. Merritt WM, Bar-Eli M, Sood AK (2010) The dicey role of Dicer: Implications for RNAi therapy. Cancer Res 70:2571-2574.
12. Georgescu MM (2010) PTEN tumor suppressor network in PI3K-Akt pathway control. Genes Cancer 1:1170-1177.
13. Crum CP, et al. (2007) The distal fallopian tube: A new model for pelvic serous carcinogenesis. Curr Opin Obstet Gynecol 19:3-9. (Pubitemid 46095865)
14. Dubeau L (2008) The cell of origin of ovarian epithelial tumours. Lancet Oncol 9:1191-1197.
15. Crum CP (2009) Intercepting pelvic cancer in the distal fallopian tube: Theories and realities. Mol Oncol 3:165-170.
16. Beck LR (1972) Comparative observations on the morphology of the mammalian periovarial sac. J Morphol 136:247-254.
17. Nagaraja AK, et al. (2008) Deletion of Dicer in somatic cells of the female reproductive tract causes sterility. Mol Endocrinol 22:2336-2352.
18. Covey TM, Edes K, Coombs GS, Virshup DM, Fitzpatrick FA (2010) Alkylation of the tumor suppressor PTEN activates Akt and ?-catenin signaling: A mechanism linking inflammation and oxidative stress with cancer. PLoS ONE 5:e13545.
19. Saad AF, HuW, Sood AK (2010) Microenvironment and pathogenesis of epithelial ovarian cancer. Horm Cancer 1:277-290.
20. King SM, et al. (2011) The impact of ovulation on fallopian tube epithelial cells: evaluating three hypotheses connecting ovulation and serous ovarian cancer. Endocr Relat Cancer 18:627-642.